Analyst Price Targets — LFCR
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| June 16, 2026 11:32 am | — | Barrington | $6.50 | $5.49 | TheFly | Lifecore price target raised to $6.50 from $6 at Barrington |
| April 29, 2026 11:33 am | — | Barrington | $6.00 | $5.12 | TheFly | Lifecore price target raised to $6 from $5.50 at Barrington |
| October 4, 2024 1:16 pm | Jacob Johnson | Stephens | $5.00 | $5.38 | StreetInsider | Stephens Reiterates Equal Weight Rating on Lifecore Biomedical (LFCR) |
| September 5, 2024 8:59 am | Matthew Hewitt | Craig-Hallum | $8.00 | $4.22 | TheFly | Craig-Hallum bullish on Lifecore, initiates with a Buy |
Latest News for LFCR
CHASKA, Minn., July 15, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”) a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced that effective on July 13, 2026, Lifecore granted a restricted stock unit (“RSU”) award with respect to 3,500 shares of its common stock under Lifecore's Equity Inducement Plan, as amended (the “Inducement…
CHASKA, Minn. , July 15, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) ("Lifecore") a fully integrated injectables contract development and manufacturing organization ("CDMO"), today announced that effective on July 13, 2026, Lifecore granted a restricted stock unit ("RSU") award with respect to 3,500 shares of its common stock under Lifecore's Equity Inducement Plan, as amended (the "Inducement…
--Agreement Supports Tech Transfer and Commercial Manufacturing of Currently Marketed Neurology Product-- --Seventh Addition to Lifecore's Late-Stage Pipeline in Seven Months-- CHASKA, Minn., June 15, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced it has signed a new agreement…
-- Agreement Calls for Tech Transfer in Preparation for Potential Commercial Manufacturing of Injectable Ophthalmic Product -- -- Sixth Addition to Late-Stage Pipeline in Seven Months -- CHASKA, Minn., June 02, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced that it has signed…
CHASKA, Minn. , May 21, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) ("Lifecore"), a fully integrated injectables contract development and manufacturing organization ("CDMO"), today announced that the company will participate in the William Blair 46th Annual Growth Stock Conference. The conference will take place June 2-4, 2026, in Chicago, IL.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for LFCR.
U.S. House Trading
No House trades found for LFCR.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.